QNTM receives FDA clearance to begin MS treatment trials
Quantum BioPharma Ltd. (NASDAQ: QNTM) received FDA clearance to begin trials for its MS treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.